Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/1999
04/22/1999WO1999019732A1 Methods and compositions for detecting hepatitis e virus
04/22/1999WO1999019495A1 Phosphodiesterase 8a
04/22/1999WO1999019490A1 Apo-3 ligand
04/22/1999WO1999019487A1 Mammoglobin homolog
04/22/1999WO1999019486A1 Cell division regulators
04/22/1999WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor
04/22/1999WO1999019483A1 Human progesterone receptor complex p23-like protein
04/22/1999WO1999019480A2 Human receptor proteins; related reagents and methods
04/22/1999WO1999019479A1 Murine model for human carcinoma
04/22/1999WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
04/22/1999WO1999019477A1 Cadherin derived growth factor and the application thereof
04/22/1999WO1999019463A1 Anticoagulant test
04/22/1999WO1999019363A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
04/22/1999WO1999019362A1 BISPECIFIC MOLECULES DIRECTED TO TUMOR ASSOCIATED GLYCOPROTEIN-72 AND Fc RECEPTOR
04/22/1999WO1999019361A1 Bonding molecules against receptor-ligand-complexes
04/22/1999WO1999019360A1 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies
04/22/1999WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
04/22/1999WO1999019358A2 Antibody against baculoviruses
04/22/1999WO1999019357A2 Cell regulatory genes, encoded products, and uses related thereto
04/22/1999WO1999019348A1 Laminins and uses thereof
04/22/1999WO1999019343A1 Viral clearance process
04/22/1999WO1999019339A1 53 human secreted proteins
04/22/1999WO1999018997A1 Potentiator for antibody against lymphoid tumor
04/22/1999WO1999018996A1 Enterococcus antigens and vaccines
04/22/1999WO1999018989A1 F-box proteins and genes
04/22/1999WO1999018987A1 Ligand binding site of rage and uses thereof
04/22/1999WO1999018986A1 Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
04/22/1999WO1999006577A3 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
04/22/1999WO1999006561A3 Chemokine receptor ccr8 dna and uses thereof
04/22/1999WO1999004011A3 Hiv-1 group o antigens and uses thereof
04/22/1999WO1999003981A8 Nucleic acid expression constructs incorporating a heterologous intron whose natural position is within the 5'untranslated region of its gene
04/22/1999WO1999002565A3 Agent for the treatment and/or prophylaxis of microcirculation disorders
04/22/1999WO1999001556A3 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
04/22/1999WO1999000668A3 Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level
04/22/1999WO1999000424A3 Antibodies and other binding molecules specific for hepatitis b viral antigens
04/22/1999WO1998053068A9 Smad7 and uses thereof
04/22/1999WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides
04/22/1999DE19745443A1 Diagnostic polyclonal antiserum specific for prion protein
04/22/1999DE19744132A1 Human anti-heavy chain binding protein antibody
04/22/1999CA2308122A1 Anticoagulant test
04/22/1999CA2307328A1 Cell division regulators
04/22/1999CA2306476A1 Enterococcus antigens and vaccines
04/22/1999CA2306455A1 Human receptor proteins; related reagents and methods
04/22/1999CA2306451A1 Methods and compositions for detecting hepatitis e virus
04/22/1999CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
04/22/1999CA2305713A1 Apo-3 ligand
04/22/1999CA2305698A1 Human progesterone receptor complex p23-like protein
04/22/1999CA2305690A1 53 human secreted proteins
04/22/1999CA2305643A1 Murine model for human carcinoma
04/22/1999CA2304169A1 Laminins and uses thereof
04/22/1999CA2275135A1 Phosphodiesterase 8a
04/21/1999EP0909820A2 Histidine kinase from Staphylococcus pneumoniae
04/21/1999EP0909817A1 Uses of gro genes and proteins
04/21/1999EP0909816A1 Anti-fas antibodies
04/21/1999EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
04/21/1999EP0909813A1 Totipotent hematopoietic stem cell receptors -flk-1 and flk-2, and their ligands
04/21/1999EP0909388A2 Immunological assay for spongiform encephalopathies
04/21/1999EP0909321A2 Mammalian chemokine reagents
04/21/1999EP0909320A1 CHEMOKINE beta-15
04/21/1999EP0909319A2 Growth arrest gene compositions and methods
04/21/1999EP0909318A1 Human stem cell antigens, dna coding therefor and their use
04/21/1999EP0909316A1 Glial cell line-derived neurotrophic factor receptor
04/21/1999EP0909278A1 Nephropathy-related immunoglobulin g and antibodies for same
04/21/1999EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
04/21/1999EP0909272A1 Helicobacter pylori adhesin binding group antigen
04/21/1999EP0909181A1 Novel compounds
04/21/1999EP0909180A1 Novel compounds
04/21/1999EP0909179A2 T-cell dependent vaccine and the cell surface receptor cd28
04/21/1999EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies
04/21/1999EP0644947B1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
04/21/1999EP0640131B1 Genetically engineered antibodies
04/21/1999CN1214733A Down-regualtion resistant C3 convertase
04/21/1999CN1214695A ErdB3 antibodies
04/21/1999CA2248169A1 Dnag
04/20/1999US5895812 Diagnostic for Sjogren's syndrome
04/20/1999US5895748 Immunoassay of paraffin-embedded biopsies; detection of specific cadherins, catenins, and plaque proteins enables accurate diagnosis of cancer and tumors
04/20/1999US5895746 Immunoassay for detecting label bound to intact trimeric alpha1-homotrimeric peptide isolated without use of proteolytic enzymes
04/20/1999US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists
04/20/1999CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
04/15/1999WO1999018441A1 Icam-4 and diagnostic uses thereof
04/15/1999WO1999018435A1 Method for analyzing annexin v in urine and use thereof
04/15/1999WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability
04/15/1999WO1999018219A1 A keratinocyte derived protease
04/15/1999WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents
04/15/1999WO1999018212A1 Natural human antibody
04/15/1999WO1999018209A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a
04/15/1999WO1999018208A1 101 human secreted proteins
04/15/1999WO1999018187A1 NOVEL clpL
04/15/1999WO1999018131A2 ANTI-BiP-ANTIBODIES IN RHEUMATOID ARTHRITIS, METHOD AND TEST KITS FOR DETECTING THEM
04/15/1999WO1999018130A1 A method for the purification of immunoglobulins
04/15/1999WO1999018129A1 Soluble single-chain t-cell receptor proteins
04/15/1999WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity
04/15/1999WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
04/15/1999WO1999017801A2 Materials and methods relating to the stimulation of cells
04/15/1999WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
04/15/1999WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
04/15/1999WO1999017796A2 Modulation of lerk-2-mediated cell adhesion
04/15/1999WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS
04/15/1999WO1999017789A1 Peptide compositions for the treatment and prevention of hiv infection
04/15/1999WO1999017741A1 Chlamydia protein, gene sequence and uses thereof
1 ... 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 ... 1494